BAY-X 1005

CAS: 128253-31-6

Ref. 3D-DFA25331

Produktinformation

• Name: BAY-X 1005
• Synonyme: 2-(4-(Quinolin-2-Yl-Methoxy)Phenyl)-2-Cyclopentylacetic Acid, Veliflapon, (2R)-cyclopentyl[4-(quinolin-2-ylmethoxy)phenyl]ethanoic acid, Cyclopentyl[4-(Quinolin-2-Ylmethoxy)Phenyl]Acetic Acid
• CAS: 128253-31-6

Beschreibung

Bay-X 1005 is a nonsteroidal anti-inflammatory drug that belongs to the class of ester linkages. It is used to treat inflammatory bowel disease and other autoimmune diseases such as rheumatoid arthritis, psoriasis, Crohn's disease, ulcerative colitis, and lupus erythematosus. Bay-X 1005 inhibits the production of PGE2 in inflamed tissue by blocking cyclooxygenase activity. This drug also has been shown to have an effect on cell factor (CD40) and stem cell factor (SCF), which are involved in inflammation. Bay-X 1005 binds to the cell receptor for SCF and blocks its ability to activate T cells and B cells. This leads to a decrease in inflammation by reducing the number of activated T cells that produce cytokines. The hydroxyl group on Bay-X 1005 may be responsible for this effect.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 361.43 g/mol
• Formel: C₂₃H₂₃NO₃
• Reinheit: Min. 95%